Please login to the form below
ICU
This page shows the latest ICU news and features for those working in and with pharma, biotech and healthcare.
AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront
This also corresponded with a reduction in the number of days patients needed in ICU and hospital. ... Previous data, published in the Lancet Infectious Diseases in June, suggested that the mAb was not effective at reducing pneumonia caused by
Latest news
-
WHO recommends ‘life-saving’ IL-6 inhibitors for severe COVID-19
On average, patients treated with these drugs were able to leave the ICU around a week earlier than those not receiving these treatments.
-
FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD
In this trial, the number of patients who died or required mechanical ventilation due to respiratory failure or ICU care by day 29 was 12% for Jakafi-treated patients and
-
PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19
At first we are not targeting ICU patients, there will be hospitalised patients, but doctors are collaborating with us to identify the different phases a sick person goes through, and determine
-
UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
On average, patients treated with these drugs were able to leave the ICU around a week earlier than those not receiving these treatments.
-
Two drugs found to reduce mortality in severe COVID-19 patients
be in an intensive care unit (ICU). ... On average, patients treated with these drugs were able to leave the ICU around a week earlier than those not receiving these treatments.
WHO recommends ‘life-saving’ IL-6 inhibitors for severe COVID-19
FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD
PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19
More from news
Approximately 2 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2016
1, 120. Hospira / Pfizer (US). ICU Medical (US). Asset Acquisition.
-
An effective commercial model for cancer care
According to studies, adding palliative care consultation to the standard of care for patients avoids unnecessary tests or treatment and reduces costs associated with ICU and hospital stays.
Deal Watch October 2016
An effective commercial model for cancer care
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
patients in ICU settings with mild and severe disease).
-
Washington HealthCare Careers
Candidates post resumes and review fresh job listings related to nurse manager, occupational therapist, pharmacist, physical therapist, RN ICU intensive care, CCU critical care, speech therapist jobs while recruiters source the
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital strategist
-
Competitive
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Digital account director
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Events Executive
-
Depending on Experience
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Live Webinar: Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- Another Landmark Lucid Workiversary
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Onyx Health Launch Creative Studio After Record Year
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Paving the way for the HCP omnichannel experience: a guide for medical affairs
- EU approves bluebird bio’s CALD gene therapy Skysona
- Ashfield Health announces three new senior hires
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
